Literature DB >> 18245132

Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab.

D Aguiar Bujanda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245132     DOI: 10.1093/annonc/mdm579

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  12 in total

Review 1.  New molecular insights into peripheral T cell lymphomas.

Authors:  Stefano A Pileri; Pier Paolo Piccaluga
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

2.  Assessment of gemcitabine, cisplatin and methylprednisolone (GEM-P) combination treatment for non-Hodgkin T cell lymphoma.

Authors:  Kein-Leong Yim; Sue Ashley
Journal:  Med Oncol       Date:  2012-07-24       Impact factor: 3.064

Review 3.  Update on the World Health Organization classification of peripheral T-cell lymphomas.

Authors:  Hilary M O'Leary; Kerry J Savage
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

4.  Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells.

Authors:  Li Wang; Wen-Yu Shi; Fan Yang; Wei Tang; Guillaume Gapihan; Mariana Varna; Zhi-Xiang Shen; Sai-Juan Chen; Christophe Leboeuf; Anne Janin; Wei-Li Zhao
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

5.  BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.

Authors:  Philippe Ratajczak; Christophe Leboeuf; Li Wang; Josette Brière; Irmine Loisel-Ferreira; Catherine Thiéblemont; Wei-Li Zhao; Anne Janin
Journal:  Mod Pathol       Date:  2012-02-10       Impact factor: 7.842

Review 6.  Immunologic Milieu of Mature T-Cell and NK-Cell Lymphomas-Implications for Therapy.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

7.  Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.

Authors:  Michael Medinger; Natalie Fischer; Alexandar Tzankov
Journal:  J Oncol       Date:  2010-05-24       Impact factor: 4.375

8.  Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.

Authors:  N K El-Mallawany; J K Frazer; P Van Vlierberghe; A A Ferrando; S Perkins; M Lim; Y Chu; M S Cairo
Journal:  Blood Cancer J       Date:  2012-04-13       Impact factor: 11.037

Review 9.  Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

Authors:  C Agostinelli; P P Piccaluga; P Went; M Rossi; A Gazzola; S Righi; T Sista; C Campidelli; P L Zinzani; B Falini; S A Pileri
Journal:  J Clin Pathol       Date:  2008-08-28       Impact factor: 3.411

10.  T-cell lymphoma with POEMS syndrome.

Authors:  Fangwen Zou; Zhenhua Li; Jin-An Ma; Zhenhua Qiu; Yi-Fang Tang; Jiao-Yun Zheng
Journal:  Oncol Lett       Date:  2014-12-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.